Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic Syndromes

NCT01913951 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndromes

Interventions

DRUG: vosaroxin
DRUG: Azacitidine

Sponsor

Washington University School of Medicine

Collaborators

[object Object]